Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 9/20 | 0.57 |
| ▸ | KDM4E | B2RXH2 | 9/20 | 0.57 |
| ▸ | MAPT | P10636 | 7/20 | 0.57 |
| ▸ | HPGD | P15428 | 7/20 | 0.57 |
| ▸ | MEN1 | O00255 | 4/20 | 0.57 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.57 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.57 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 2/20 | 0.44 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.40 |
| ▸ | APOBEC3A | P31941 | 1/20 | 0.33 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 2/20 | 0.33 |
| ▸ | ALPG | P10696 | 1/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.32 |
| ▸ | RECQL | P46063 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Bromide SCHEMBL2951033 | 0.98 | ALDH1A1 (0.60) | ALDH1A1KDM4EMAPTHPGDMEN1 | |
| Bromide SCHEMBL8390275 | 0.98 | ALDH1A1 (0.60) | ALDH1A1KDM4EMAPTHPGDMEN1 | |
| Bromide SCHEMBL8390272 | 0.97 | ALDH1A1 (0.58) | ALDH1A1KDM4EMAPTHPGDMEN1 | |
| SCHEMBL8987983 | 0.91 | ALDH1A1 (0.49) | ALDH1A1KDM4EMAPTHPGDMEN1 | |
| SCHEMBL6935716 | 0.84 | ALDH1A1 (0.51) | ALDH1A1KDM4EMAPTHPGDMEN1 | |
| Bromide SCHEMBL2954113 | 0.83 | KMT2A (0.55) | ALDH1A1KDM4EMAPTHPGDMEN1 | |
| Hydrochloric Acid SCHEMBL1520138 | 0.83 | ALDH1A1 (0.50) | ALDH1A1KDM4EMAPTHPGDMEN1 | |
| Bromide SCHEMBL8385551 | 0.83 | ALDH1A1 (0.54) | ALDH1A1KDM4EMAPTHPGDMEN1 | |
| Bromide SCHEMBL2954205 | 0.83 | ALDH1A1 (0.54) | ALDH1A1KDM4EMAPTHPGDMEN1 | |
| Bromide SCHEMBL8385548 | 0.81 | ALDH1A1 (0.53) | ALDH1A1KDM4EMAPTHPGDMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2778262-B1 | COPPER PLATING METHOD FOR THE MANUFACTURE OF SOLAR CELLS | MACDERMID ENTHONE AMERICA LLC (US) | 2019-05-08 | — | — | EP | claimed |
| CN-1142778-C | Use of thiazolium compounds for preventing and reversing the formation of advanced glycosylation endproducts | ¶ | 2004-03-24 | — | — | CN | claimed |
| EP-0808163-B1 | USE OF THIAZOLIUM COMPOUNDS FOR PREVENTING AND REVERSING THE FORMATION OF ADVANCED GLYCOSYLATION ENDPRODUCTS | ALTEON INC (US) | 2003-07-23 | — | — | EP | claimed |
| US-6440749-B1 | ADMINISTERING A THIAZOLE COMPOUND | ALTEON. INC. | 2002-08-27 | — | — | US | claimed |
| EP-0743574-B1 | Migration imaging members | XEROX CORP (US) | 2000-12-27 | — | — | EP | claimed |
| EP-0743573-B1 | Method for obtaining image contrast migration imaging members | XEROX CORP (US) | 2000-09-06 | — | — | EP | claimed |
| EP-0615854-B1 | Recording sheets containing cationic sulphur compounds | XEROX CORP (US) | 1997-06-04 | — | — | EP | claimed |
| US-11192908-B2 | Octamolybdate compounds exhibiting bright emission | NANOCO 2D MATERIALS LIMITED (GB) | 2021-12-07 | — | — | US | disclosed |
| US-20200055884-A1 | Octamolybdate Compounds Exhibiting Bright Emission | NANOCO TECHNOLOGIES LIMITED (GB) | 2020-02-20 | — | — | US | disclosed |
| EP-2778262-A1 | Copper plating solutions and method of making and using such solutions | Omg Electronic Chemicals LLC (US) | 2014-09-17 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11192908-B2 | Octamolybdate compounds exhibiting bright emission | KCNN4, PUF60, OCIAD1 | ALDH1A1 2429/4885KDM4E 287/4885MAPT 55/4885 |
| US-20200055884-A1 | Octamolybdate Compounds Exhibiting Bright Emission | KCNN4, PUF60, OCIAD1 | ALDH1A1 2429/4885KDM4E 287/4885MAPT 55/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.